Clinical Trials in Houston

Showing 2101-2120 of 8,625 trials

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

NCT05848817

The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.

Myopia

Mann Eye Institute50 participantsStarted May 2023

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

NCT02131597

This phase II trial studies how well guadecitabine works in treating patients with myelodysplastic syndromes that are at higher risk for becoming acute myeloid leukemia. Guadecitabine may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

High Risk Myelodysplastic Syndrome

M.D. Anderson Cancer Center100 participantsStarted Nov 2014

Houston, Texas, United States

TERMINATEDPhase 1< 1 mile

9-ING-41 in Pediatric Patients With Refractory Malignancies.

NCT04239092

9-ING-41 has anti-cancer clinical activity with no significant toxicity in adult patients. This Phase 1 study will study its efficacy in paediatric patients with advanced malignancies.

Refractory CancerRefractory NeoplasmCancer Pediatric+8 more

Actuate Therapeutics Inc.40 participantsStarted Jun 2020

San Francisco, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +6 more locations

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Find Trials by Condition in Houston

An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Enhancing the Effectiveness of Home-delivery Based Produce Prescription Program Implementation Strategies

Application of Virtual Reality Technology to Treatment of Social Anxiety

A Study to Compare Nighttime Aligners to Daytime Aligners

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

A Study of RSLV-132 in Females With Sjögren's Disease

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)